02 December
2022
Marechale Capital
plc
("Marechale Capital", “Marechale” or
the "Company")
Half-yearly
Results
Marechale Capital plc, an established City of London based corporate finance house
with a long-term track record and a strong reputation for advising
and financing high growth consumer brands, leisure, clean energy,
mineral extraction and technology companies, announces its
unaudited half-yearly results for the six months ended 31 October 2022 (“the Period”).
Chairman’s Statement
Following the significant value uplift in the Company’s
investments reported in Marechale’s full year results released in
August 2022, the Board continues to
remain positive about the outlook for its investments.
While Marechale Capital continues to see interesting corporate
finance and advisory projects where it can take founders shares and
warrants as part of its advisory fees, the market remains a
challenging environment to raise capital. This has resulted in
advisory projects launched in the summer not being completed by the
end of the Period. Marechale continues to look for new funding
partners alongside its traditional investor relationships.
During the six months ended 31 October
2022 the company generated gross profits of £72,020 (2021:
£227,435) and delivered an operating loss of £18,995 (2021: Loss
£15,000), resulting in an overall loss before tax of £179,502
(compared to a Profit for the same period in 2021 of £1,501,000
which benefitted from significant investment revenues).
As reported in August 2022, the
Company’s balance sheet shows a net asset value of £3,483,929
(2021: £2,395,105), representing 3.66p of value per share in issue.
The Company remains positive about the investments that it holds in
its client companies. As at 31 October
2022 the Company had £246,808 of cash reserves.
The Board is working on a number of initiatives to create
further value for shareholders over and above its core investment
portfolio and corporate finance projects. Furthermore, the Board is
hopeful to be able to announce realisations on some of the
Company’s investments in the next six months
Whist the current economic climate is difficult, Marechale
Capital is working hard and is convinced that there will be good
advisory and investment opportunities in its core hospitality,
renewable, clean energy and technology sectors over the short to
medium term.
Mark Warde-Norbury
Chairman
The information communicated in this announcement contains
inside information for the purposes of Article 7 of the Market
Abuse Regulation (EU) No. 596/2014
For further information please contact:
Marechale
Capital
Mark Warde-Norbury / Patrick Booth-Clibborn |
Tel: +44 (0)20 7628 5582 |
Cairn Financial
Advisers LLP
Jo Turner / Sandy Jamieson |
Tel: +44 (0)20 7213 0880 |
Income
Statement (unaudited) |
|
|
|
|
6 months ended 31
October |
|
|
|
2022 |
|
2021 |
|
|
|
|
|
£ |
|
|
|
Revenue |
|
|
|
168,001 |
|
497,194 |
|
|
Cost of sales |
|
|
|
(95,981) |
|
(269,759) |
|
|
|
|
|
|
|
|
|
|
|
Gross
profit |
|
|
|
72,020 |
|
227,435 |
|
|
|
|
|
|
|
|
|
|
|
Administrative expenses |
|
|
(251,015) |
|
(242,926) |
|
|
|
|
|
|
|
|
|
|
|
Operating
loss |
|
|
(178,995) |
|
(15,491) |
|
|
|
|
|
|
|
|
|
|
|
Investment
revenues |
|
|
- |
|
1,517,036 |
|
|
Interest
paid |
(507) |
|
(310) |
|
|
|
|
|
|
|
|
|
(Loss/profit before
tax |
|
|
|
(179,502) |
|
1,501,235 |
|
|
Taxation |
|
|
- |
|
- |
|
|
|
|
|
|
|
|
|
|
|
(Loss)/profit after
tax |
|
|
|
(179,502) |
|
1,501,235 |
|
|
|
|
|
|
|
(Loss)/profit per
share |
|
|
|
|
|
|
|
|
|
|
|
(Pence) |
|
(Pence) |
|
|
-
Basic |
|
(1.70) |
|
1.70 |
|
|
-
Diluted |
|
|
(1.63) |
|
1.65 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance
Sheet (unaudited) |
|
|
|
|
|
As at |
|
|
|
|
31
October |
31
October |
|
|
|
|
|
2022 |
2021 |
Current
assets |
|
|
|
|
|
|
Available
for sale investments |
|
|
3,116,441 |
1,982,566 |
Trading
investments |
|
|
|
146,589 |
90,013 |
Trade and
other receivables |
|
|
54,356 |
41,884 |
Cash and
cash equivalents |
|
|
246,808 |
357,875 |
|
|
|
|
|
3,564,194 |
2,472,338 |
|
|
|
|
|
|
|
Current
liabilities |
|
|
|
|
|
Trade and other payables
PAYE
Bounce-back Loan |
|
|
|
(59,627)
(10,638)
(10,000) |
(56,950)
(10,283)
(10,000) |
|
|
|
|
|
|
|
Total
current liabilities |
|
|
|
(80,265) |
(77,233) |
|
|
|
|
|
|
|
Net current
assets |
|
|
|
|
3,483,929 |
2,395,105 |
|
|
|
|
|
|
|
Bounce-back Loan –
long-term |
|
|
|
|
(27,500) |
(37,500) |
|
|
|
|
|
|
|
Net assets |
|
|
|
|
3,456,429 |
2,357,605 |
Equity |
|
|
|
|
|
|
Capital
and reserves attributable to equity shareholders |
|
|
Share
capital
Share premium |
|
|
|
|
763,023
328,413 |
707,690
181,247 |
Reserve
for own shares |
|
|
|
(50,254) |
(50,254) |
Retained
profits/ (losses) |
|
|
|
2,346,660 |
1,465,594 |
Reserve
for share based payments |
|
|
|
68,587 |
53,328 |
|
|
|
|
3,456,429 |
2,357,605 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash
Flow Statement (unaudited) |
|
|
|
6
months ended |
31
October |
31
October |
|
|
|
|
|
20212 |
2021 |
|
|
|
|
|
£ |
£ |
Net
cash from operating activities |
|
|
|
|
Loss/profit after tax |
|
(179,502) |
1,501,235 |
Provision for share based payments
Reverse unrealised gains on investments
Reverse interest paid |
|
|
6,275
-
507 |
10,619
(1,517,036)
310 |
|
|
|
|
|
|
|
Operating cash flows before movements in working
capital |
(172,720) |
(4,872) |
|
|
|
|
|
|
|
Movement in working capital |
|
|
|
|
(Increase)/decrease in receivables |
|
|
(10,580) |
8,713 |
Increase
in payables |
|
|
12,895 |
6,018 |
|
|
|
|
|
|
|
Net movement in
working capital |
|
|
|
|
2,315 |
14,731 |
|
|
|
|
|
|
Operating cash flow |
|
|
|
(170,405) |
9,859 |
|
|
|
|
|
|
|
Investment activities |
|
|
|
|
|
Expenditure on available for sale investments |
- |
(42,462) |
Proceeds from sale of
investments |
|
|
|
|
8,750 |
|
|
|
|
|
|
|
|
Cash
flow from investing activities |
|
|
8,750 |
(42,462) |
|
|
|
|
|
|
|
Financing
Share Capital
Bounce-back Loan repayments
Interest paid
Net financing |
|
|
|
-
(5,000)
(507)
(5,507) |
160,000
(2,500)
(310)
157,190 |
Net
(decrease)/ increase in cash and cash equivalents |
|
(167,162) |
124,587 |
|
|
|
|
|
|
|
Cash
and cash equivalents at start of the period |
413,970 |
233,287 |
Cash
and cash equivalents at end of the period |
246,808 |
357,874 |
|
|
|
|
|
|
|
Increase in cash and cash equivalents |
|
(167,162) |
124,587 |
This financial information has been prepared in accordance with
IFRS and International Financial Reporting Interpretations
Committee ('IFRIC') interpretations adopted by the European Union,
and with those parts of the Companies Act 2006 applicable to
companies reporting under IFRS, with the prior period being
reported on the same basis.